4//SEC Filing
Anacor Pharmaceuticals, Inc. 4
Accession 0001209191-15-022573
CIK 0001411158operating
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 7:18 PM ET
Size
7.9 KB
Accession
0001209191-15-022573
Insider Transaction Report
Form 4
Plattner Jacob j
Senior VP Research
Transactions
- Sale
Common Stock
2015-03-02$43.99/sh−6,475$284,815→ 45,000 total(indirect: See Footnote) - Sale
Common Stock
2015-03-02$44.60/sh−400$17,841→ 44,600 total(indirect: See Footnote)
Holdings
- 5,020
Common Stock
Footnotes (4)
- [F1]This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $43.44 to $44.41, inclusive.
- [F3]These shares are held by Jacob & Jeanne Plattner Trust U/A 7/17/04, Jacob Plattner & Jeanne Plattner, Trustees.
- [F4]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $44.55 to $44.65, inclusive.
Documents
Issuer
Anacor Pharmaceuticals, Inc.
CIK 0001411158
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001411158
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 7:18 PM ET
- Size
- 7.9 KB